China Pharma Holdings Seeks Approval of Generic Hypertension Drug
January 22, 2010 at 01:08 AM EST
China Pharma Holdings reported that its clinical trials for a generic version of Candesartan, an anti-hypertension drug, have been completed successfully, and China Pharma has submitted a generic drug production application for Candesartan to the SFDA. Candesartan Cilexetil is a prodrug of Candesartan, which allows the product to be administered orally and also means that it remains effective for a full day. More details... Stock Symbol: (NYSE: CPHI)